🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical trial is to compare the blood tafamidis concen...
Status
Active Not Recruiting
Location
P-One Clinic
Start Date
2026-05-11
Trial ID
NCT07587697
This observational study aims to describe the characteristics, health outco...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2026-04-02
Trial ID
NCT07494656
Treatments Being Tested
A study of patients with hereditary transthyretin amyloidosis (ATTRv) and w...
Status
Completed
Location
Hospital Universitari de Bellvitge
Start Date
2022-10-24
Trial ID
NCT05560555
Treatments Being Tested
2 different formulations of tafamidis will be compared under both fed and f...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2017-09-29
Trial ID
NCT03280173
Treatments Being Tested
The purpose of this clinical trial is to compare the amount of tafamidis in...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2024-12-20
Trial ID
NCT06705569
Treatments Being Tested
This is a 2 part study. In part 1 of the study, 3 different formulations of...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-09
Trial ID
NCT02534740
The purpose of this clinical trial is to compare the amount of tafamidis in...
Status
Terminated
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2026-03-23
Trial ID
NCT07470866
Treatments Being Tested
The purpose of this study is to learn about the safety of Tafamidis for the...
Status
Completed
Location
Sri Jayadeva Institute of Cardiovascular Sciences and Research
Start Date
2024-03-25
Trial ID
NCT06086353
Treatments Being Tested
This study will examine the clinical effectiveness of Tafamidis in patients...
Status
Completed
Location
Pfizer
Start Date
2023-03-08
Trial ID
NCT05139680
Treatments Being Tested
This is a national, multi-center, single-arm study, open-label to patients ...
Status
Completed
Location
Peking University First Hospital
Start Date
2021-07-22
Trial ID
NCT04814186
Treatments Being Tested